R

Renew Biopharma, Inc.

3 employees

Pre-clinical stage syn-bio creating proprietary drug molecules to treat neuroinflammatory diseases .

Basic info

Industry

biotechnology research

Sectors

molecular biology
Biotechnology
biotechnology
best-in class enzymes
Microbiology
neurodegeneration
Biosynthesis
neurotherapeutics
Pathway Engineering
neurodegenerative diseases
Blood-Brian-Barrier
Analytical Chemistry
Microorganisms
Traumatic Brain Injury
Medicinal Chemistry In Microbes
Advanced Engineering
Cell Optimization
Neuroinflammation
Pharmaceutical
Drug Discovery
Biodiscovery
synthetic biology
Type 2 diabetes Mellitus
Synthetic Biology
Health Care
alkylresorcinol scaffold derivatives
PPAR Receptors
cannabinoids
Medical
Pharmaceuticals

Date founded

2016

FAQ